Summary: The collaboration, one of many IBM is planning to widen cognitive computing's footprint, will be the first Watson implementation for genomic research. <\/p>\n
IBM's Watson business unit and the New York Genome Center will test a cognitive computing prototype aimed at allowing oncologists to better tailor cancer care. <\/p>\n
IBM's Watson unit turnover: Worrisome or the norm? <\/p>\n
IBM CEO Rometty: Watson, cognitive computing mainstreaming begins <\/p>\n
IBM forms Watson Business Group: Will commercialization follow? <\/p>\n
IBM Watson: How the Jeopardy-winning supercomputer was born, and what it wants to do next <\/p>\n
The collaboration, one of many IBM is planning to widen cognitive computing's footprint, will be the first Watson implementation for genomic research. <\/p>\n
Under the partnership: <\/p>\n
Ultimately, IBM wants to use the Watson prototype for a clinical study by the New York Genome Center. The software and analytics tools have been under development for the past decade at IBM Research's Computational Biology Center. <\/p>\n
The New York Genome Center specializes in experimental design, genome sequencing, bioinformatics and the computing and data storage infrastructure to crunch the data. <\/p>\n
<\/p>\n
Go here to see the original: Summary: The collaboration, one of many IBM is planning to widen cognitive computing's footprint, will be the first Watson implementation for genomic research. IBM's Watson business unit and the New York Genome Center will test a cognitive computing prototype aimed at allowing oncologists to better tailor cancer care. Continue reading
\nIBM, New York Genome Center prep Watson prototype<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"